Search

Your search keyword '"Hsiao, Chin-Fu"' showing total 555 results

Search Constraints

Start Over You searched for: Author "Hsiao, Chin-Fu" Remove constraint Author: "Hsiao, Chin-Fu"
555 results on '"Hsiao, Chin-Fu"'

Search Results

2. Survival of advanced/recurrent gastrointestinal stromal tumors treated with tyrosine kinase inhibitors in Taiwan: a nationwide registry study

3. Genome-wide association study of lung adenocarcinoma in East Asia and comparison with a European population

4. Low-dose CT screening among never-smokers with or without a family history of lung cancer in Taiwan: a prospective cohort study

5. Role of chemotherapy in patients with nasopharynx carcinoma treated with radiotherapy (MAC-NPC): an updated individual patient data network meta-analysis

9. Polygenic Risk Score, Environmental Tobacco Smoke, and Risk of Lung Adenocarcinoma in Never-Smoking Women in Taiwan

10. O15-3 Nivolumab plus ipilimumab (N+I) for potentially resectable hepatocellular carcinoma (HCC): Efficacy and surgical outcome

11. Low-dose CT screening among never-smokers with or without a family history of lung cancer in Taiwan: a prospective cohort study

13. Insulin Resistance: Regression and Clustering

17. Role of chemotherapy in patients with nasopharynx carcinoma treated with radiotherapy (MAC-NPC): an updated individual patient data network meta-analysis

18. Supplementary Data from Recalibrating Risk Prediction Models by Synthesizing Data Sources: Adapting the Lung Cancer PLCO Model for Taiwan

19. Supplementary Figure from Recalibrating Risk Prediction Models by Synthesizing Data Sources: Adapting the Lung Cancer PLCO Model for Taiwan

20. Data from Recalibrating Risk Prediction Models by Synthesizing Data Sources: Adapting the Lung Cancer PLCO Model for Taiwan

21. Supplementary Figure from Impaired Chromatin Remodeling Predicts Better Survival to Modified Gemcitabine and S-1 plus Nivolumab in Advanced Biliary Tract Cancer: A Phase II T1219 Study

22. Supplementary Table from Impaired Chromatin Remodeling Predicts Better Survival to Modified Gemcitabine and S-1 plus Nivolumab in Advanced Biliary Tract Cancer: A Phase II T1219 Study

24. Low-dose CT screening among never-smokers with or without a family history of lung cancer in Taiwan: a prospective cohort study

26. Genetic Variation in Aldosterone Synthase Predicts Plasma Glucose Levels

32. Recalibrating Risk Prediction Models by Synthesizing Data Sources: Adapting the Lung Cancer PLCO Model for Taiwan

33. Impaired Chromatin Remodeling Predicts Better Survival to Modified Gemcitabine and S-1 plus Nivolumab in Advanced Biliary Tract Cancer: A Phase II T1219 Study

36. Trial Designs for Integrating Novel Therapeutics into the Management of Intermediate-Stage Hepatocellular Carcinoma

37. Three-Stage Pooled Plasma Hepatitis C Virus RNA Testing for the Identification of Acute HCV Infections in At-Risk Populations

39. Analysis of Heritability and Shared Heritability Based on Genome-Wide Association Studies for 13 Cancer Types

40. Genetic Modifiers of Progression-Free Survival in Never-Smoking Lung Adenocarcinoma Patients Treated with First-Line Tyrosine Kinase Inhibitors

41. Association between GWAS-identified lung adenocarcinoma susceptibility loci and EGFR mutations in never-smoking Asian women, and comparison with findings from Western populations

42. Genetic polymorphisms in the opioid receptor mu1 gene are associated with changes in libido and insomnia in methadone maintenance patients

43. Interactions between household air pollution and GWAS-identified lung cancer susceptibility markers in the Female Lung Cancer Consortium in Asia (FLCCA)

47. Meta-analysis of genome-wide association studies identifies multiple lung cancer susceptibility loci in never-smoking Asian women

Catalog

Books, media, physical & digital resources